Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-16 | 2023-07-05 | 195139 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-06-16 | 2023-06-27 | 195136 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195133 |
| TEVA-AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-16 | 2023-07-06 | 195130 |
| ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195127 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195124 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-06-16 | 2023-08-18 | 195121 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-07-05 | 195118 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
| PEDIATRIX | 160MG | SOLUTION | Resolved | 2023-06-16 | 2023-06-27 | 195106 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-10-03 | 195103 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-10-06 | 195078 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
| CALMYLIN ACE | 10MG 7.5MG 100MG | SYRUP | Resolved | 2023-06-16 | 2023-10-31 | 195061 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-16 | 2024-01-19 | 195052 |
| CALMYLIN PSE WITH CODEINE | 100MG 30MG 3.3MG | SYRUP | Resolved | 2023-06-16 | 2023-07-06 | 195042 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |